2019
DOI: 10.1016/j.biochi.2019.07.009
|View full text |Cite
|
Sign up to set email alerts
|

The relationship between molecular content of mesenchymal stem cells derived exosomes and their potentials: Opening the way for exosomes based therapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
24
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(24 citation statements)
references
References 128 publications
0
24
0
Order By: Relevance
“…Exosomal biomarkers possess multiple advantages compared to cell-free biomarkers. Cell-free biomarkers continuously oppose to blood degrading enzymes while exosomal biomarkers are encapsulated inside the vesicles and are more stable outside of the body after isolation so that they could be reliable than cell-free biomarkers like RNAs, that are most prone to degradation [13].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Exosomal biomarkers possess multiple advantages compared to cell-free biomarkers. Cell-free biomarkers continuously oppose to blood degrading enzymes while exosomal biomarkers are encapsulated inside the vesicles and are more stable outside of the body after isolation so that they could be reliable than cell-free biomarkers like RNAs, that are most prone to degradation [13].…”
Section: Discussionmentioning
confidence: 99%
“…Other methods including, affinity chromatography method [57] and specially the exosome isolation kits are mostly used for exosome isolation [58]. As discussed in detail in our previous review [13], exosomes contents are heterogeneous and dependent on the methods of isolation and purification [59]. In our included studies three methods of exosome isolation (UC, Kit and SEC) and mostly UC and exoquic were used.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additionally, thorough characterization of the molecular content of each EV subpopulation (microvesicles, exosomes, exomeres, etc.) will be necessary to support the potential therapeutic use of stem cell EVs (Jafari et al, 2019). A more comprehensive assessment relating to the production of EV therapeutics has also been published by Gimona et al (2017).…”
Section: Future Perspectivesmentioning
confidence: 99%
“…Moreover, several studies have revealed that MSC-derived exosomes as cargo carriers possess similar immune modulatory potential. Compared with MSCs, exosomes are stable, have no risk of aneuploidy and carry a lower possibility of immune rejection after therapy (Yu et al, 2014;Jafari et al, 2019). Interestingly, exosomes derived from AD-MSCs have been shown to inhibit cancer progression by promoting anti-cancer immunity (Lou et al, 2017) and by down-regulating the expression of vascular endothelial growth factor (VEGF) in mice .…”
Section: Discussionmentioning
confidence: 99%